share_log

Semler Scientific to Present at Upcoming Investor Conferences

Semler Scientific to Present at Upcoming Investor Conferences

Semler Science將出席即將舉行的投資者大會
PR Newswire ·  2021/08/26 08:06

SANTA CLARA, Calif., Aug. 26, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that Chief Executive Officer Doug Murphy-Chutorian, M.D. and Chief Marketing Officer Dennis Rosenberg will participate in the following investor conferences that are being held virtually in September.

加利福尼亞州聖克拉拉2021年8月26日/美通社/--Semler Science,Inc.(OTCQB:SMLR)是一家提供技術解決方案以提高醫療保健提供者臨牀有效性和效率的公司,該公司今天宣佈,首席執行官Doug Murphy-Chutorian醫學博士兼首席營銷官丹尼斯·羅森伯格將參加以下投資者會議,這些會議實際上是在9月份舉行的。

Colliers 2021 Institutional Investor Conference
Date: September 9, 2021
Format: One-on-one investor meetings

Colliers 2021年機構投資者大會
日期:2021年9月9日形式:一對一投資者會議

H.C. Wainwright & Co. 23rd Annual Global Investment Conference
Date: September 13, 2021
Format: On-demand corporate presentation is available beginning at 7:00 AM ET on September 13, 2021; one-on-one meetings. The webcast of the presentation will be archived for 90 days and may be accessed through the following link: https://journey.ct.events/view/557ff96b-03cc-487d-a12a-85504df11403.

H.C.温賴特公司第23屆全球投資年會
日期:2021年9月13日格式:從以下位置開始提供點播公司演示文稿美國東部時間上午7:002021年9月13日;一對一會面。演示文稿的網絡直播將存檔90天,可通過以下鏈接訪問:Https://journey.ct.events/view/557ff96b-03cc-487d-a12a-85504df11403.

2021 Best Ideas Growth (BIG5) Conference hosted by Lake Street Securities
Date: September 14 & 15, 2021
Format: One-on-one meetings

2021年最佳創意增長(BIG5)大會由Lake Street Securities主辦
日期:2021年9月14日和15日形式:一對一會議

About Semler Scientific, Inc.:
Semler Scientific, Inc. is a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Semler Scientific's mission is to develop, manufacture and market innovative products and services that assist its customers in evaluating and treating chronic diseases. Semler Scientific commercially launched its first patented and U.S. Food and Drug Administration, or FDA, cleared product in 2011, and received FDA 510(k) clearance for QuantaFlo®, the next generation version of this product, in 2015. QuantaFlo® is a rapid point-of-care test that measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease. QuantaFlo® is used by Semler Scientific's customers to more comprehensively evaluate their patients for risk of heart attacks and strokes. Semler Scientific believes it is positioned to provide valuable information to its insurance company and physician customers, which in turn permits them to better guide patient care. Additional information about Semler Scientific can be found at semlerscientific.com.

關於塞姆勒科學公司:
Semler Science,Inc.是一家提供技術解決方案的公司,旨在提高醫療保健提供者的臨牀效果和效率。賽姆勒科學公司的使命是開發、製造和銷售創新的產品和服務,幫助其客户評估和治療慢性病。賽姆勒科學公司於2011年在商業上推出了其首個獲得專利的美國食品和藥物管理局(FDA)批准的產品,並獲得了FDA對QuantaFlo的510(K)批准®,這款產品的下一代版本,在2015年。量子流®是一種快速的護理點測試,測量四肢的動脈血流,以幫助診斷外周動脈疾病。量子流®Semler Science的客户使用該軟件來更全面地評估他們的患者心臟病發作和中風的風險。Semler Science相信,它的定位是向其保險公司和醫生客户提供有價值的信息,這反過來又允許他們更好地指導患者護理。欲瞭解有關Semler Science公司的更多信息,請訪問SemlerScience fic.com。

INVESTOR CONTACT:
Susan A. Noonan
S.A. Noonan Communications
[email protected]
212 966 3650

投資者聯繫方式:
蘇珊·努南(Susan A.Noonan)美國努南通信公司(S.A.Noonan Communications)[受電子郵件保護]212 966 3650

SOURCE Semler Scientific, Inc.

來源:塞姆勒科學公司

Related Links

相關鏈接

http://semlerscientific.com

Http://semlerscientific.com

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論